Cargando…
Clinical clustering with prognostic implications in Japanese COVID-19 patients: report from Japan COVID-19 Task Force, a nation-wide consortium to investigate COVID-19 host genetics
BACKGROUND: The clinical course of coronavirus disease (COVID-19) is diverse, and the usefulness of phenotyping in predicting the severity or prognosis of the disease has been demonstrated overseas. This study aimed to investigate clinically meaningful phenotypes in Japanese COVID-19 patients using...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9472186/ https://www.ncbi.nlm.nih.gov/pubmed/36104674 http://dx.doi.org/10.1186/s12879-022-07701-y |
_version_ | 1784789251915776000 |
---|---|
author | Otake, Shiro Chubachi, Shotaro Namkoong, Ho Nakagawara, Kensuke Tanaka, Hiromu Lee, Ho Morita, Atsuho Fukushima, Takahiro Watase, Mayuko Kusumoto, Tatsuya Masaki, Katsunori Kamata, Hirofumi Ishii, Makoto Hasegawa, Naoki Harada, Norihiro Ueda, Tetsuya Ueda, Soichiro Ishiguro, Takashi Arimura, Ken Saito, Fukuki Yoshiyama, Takashi Nakano, Yasushi Mutoh, Yoshikazu Suzuki, Yusuke Murakami, Koji Okada, Yukinori Koike, Ryuji Kitagawa, Yuko Kimura, Akinori Imoto, Seiya Miyano, Satoru Ogawa, Seishi Kanai, Takanori Fukunaga, Koichi |
author_facet | Otake, Shiro Chubachi, Shotaro Namkoong, Ho Nakagawara, Kensuke Tanaka, Hiromu Lee, Ho Morita, Atsuho Fukushima, Takahiro Watase, Mayuko Kusumoto, Tatsuya Masaki, Katsunori Kamata, Hirofumi Ishii, Makoto Hasegawa, Naoki Harada, Norihiro Ueda, Tetsuya Ueda, Soichiro Ishiguro, Takashi Arimura, Ken Saito, Fukuki Yoshiyama, Takashi Nakano, Yasushi Mutoh, Yoshikazu Suzuki, Yusuke Murakami, Koji Okada, Yukinori Koike, Ryuji Kitagawa, Yuko Kimura, Akinori Imoto, Seiya Miyano, Satoru Ogawa, Seishi Kanai, Takanori Fukunaga, Koichi |
author_sort | Otake, Shiro |
collection | PubMed |
description | BACKGROUND: The clinical course of coronavirus disease (COVID-19) is diverse, and the usefulness of phenotyping in predicting the severity or prognosis of the disease has been demonstrated overseas. This study aimed to investigate clinically meaningful phenotypes in Japanese COVID-19 patients using cluster analysis. METHODS: From April 2020 to May 2021, data from inpatients aged ≥ 18 years diagnosed with COVID-19 and who agreed to participate in the study were collected. A total of 1322 Japanese patients were included. Hierarchical cluster analysis was performed using variables reported to be associated with COVID-19 severity or prognosis, namely, age, sex, obesity, smoking history, hypertension, diabetes mellitus, malignancy, chronic obstructive pulmonary disease, hyperuricemia, cardiovascular disease, chronic liver disease, and chronic kidney disease. RESULTS: Participants were divided into four clusters: Cluster 1, young healthy (n = 266, 20.1%); Cluster 2, middle-aged (n = 245, 18.5%); Cluster 3, middle-aged obese (n = 435, 32.9%); and Cluster 4, elderly (n = 376, 28.4%). In Clusters 3 and 4, sore throat, dysosmia, and dysgeusia tended to be less frequent, while shortness of breath was more frequent. Serum lactate dehydrogenase, ferritin, KL-6, d-dimer, and C-reactive protein levels tended to be higher in Clusters 3 and 4. Although Cluster 3 had a similar age as Cluster 2, it tended to have poorer outcomes. Both Clusters 3 and 4 tended to exhibit higher rates of oxygen supplementation, intensive care unit admission, and mechanical ventilation, but the mortality rate tended to be lower in Cluster 3. CONCLUSIONS: We have successfully performed the first phenotyping of COVID-19 patients in Japan, which is clinically useful in predicting important outcomes, despite the simplicity of the cluster analysis method that does not use complex variables. |
format | Online Article Text |
id | pubmed-9472186 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-94721862022-09-14 Clinical clustering with prognostic implications in Japanese COVID-19 patients: report from Japan COVID-19 Task Force, a nation-wide consortium to investigate COVID-19 host genetics Otake, Shiro Chubachi, Shotaro Namkoong, Ho Nakagawara, Kensuke Tanaka, Hiromu Lee, Ho Morita, Atsuho Fukushima, Takahiro Watase, Mayuko Kusumoto, Tatsuya Masaki, Katsunori Kamata, Hirofumi Ishii, Makoto Hasegawa, Naoki Harada, Norihiro Ueda, Tetsuya Ueda, Soichiro Ishiguro, Takashi Arimura, Ken Saito, Fukuki Yoshiyama, Takashi Nakano, Yasushi Mutoh, Yoshikazu Suzuki, Yusuke Murakami, Koji Okada, Yukinori Koike, Ryuji Kitagawa, Yuko Kimura, Akinori Imoto, Seiya Miyano, Satoru Ogawa, Seishi Kanai, Takanori Fukunaga, Koichi BMC Infect Dis Research BACKGROUND: The clinical course of coronavirus disease (COVID-19) is diverse, and the usefulness of phenotyping in predicting the severity or prognosis of the disease has been demonstrated overseas. This study aimed to investigate clinically meaningful phenotypes in Japanese COVID-19 patients using cluster analysis. METHODS: From April 2020 to May 2021, data from inpatients aged ≥ 18 years diagnosed with COVID-19 and who agreed to participate in the study were collected. A total of 1322 Japanese patients were included. Hierarchical cluster analysis was performed using variables reported to be associated with COVID-19 severity or prognosis, namely, age, sex, obesity, smoking history, hypertension, diabetes mellitus, malignancy, chronic obstructive pulmonary disease, hyperuricemia, cardiovascular disease, chronic liver disease, and chronic kidney disease. RESULTS: Participants were divided into four clusters: Cluster 1, young healthy (n = 266, 20.1%); Cluster 2, middle-aged (n = 245, 18.5%); Cluster 3, middle-aged obese (n = 435, 32.9%); and Cluster 4, elderly (n = 376, 28.4%). In Clusters 3 and 4, sore throat, dysosmia, and dysgeusia tended to be less frequent, while shortness of breath was more frequent. Serum lactate dehydrogenase, ferritin, KL-6, d-dimer, and C-reactive protein levels tended to be higher in Clusters 3 and 4. Although Cluster 3 had a similar age as Cluster 2, it tended to have poorer outcomes. Both Clusters 3 and 4 tended to exhibit higher rates of oxygen supplementation, intensive care unit admission, and mechanical ventilation, but the mortality rate tended to be lower in Cluster 3. CONCLUSIONS: We have successfully performed the first phenotyping of COVID-19 patients in Japan, which is clinically useful in predicting important outcomes, despite the simplicity of the cluster analysis method that does not use complex variables. BioMed Central 2022-09-14 /pmc/articles/PMC9472186/ /pubmed/36104674 http://dx.doi.org/10.1186/s12879-022-07701-y Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Otake, Shiro Chubachi, Shotaro Namkoong, Ho Nakagawara, Kensuke Tanaka, Hiromu Lee, Ho Morita, Atsuho Fukushima, Takahiro Watase, Mayuko Kusumoto, Tatsuya Masaki, Katsunori Kamata, Hirofumi Ishii, Makoto Hasegawa, Naoki Harada, Norihiro Ueda, Tetsuya Ueda, Soichiro Ishiguro, Takashi Arimura, Ken Saito, Fukuki Yoshiyama, Takashi Nakano, Yasushi Mutoh, Yoshikazu Suzuki, Yusuke Murakami, Koji Okada, Yukinori Koike, Ryuji Kitagawa, Yuko Kimura, Akinori Imoto, Seiya Miyano, Satoru Ogawa, Seishi Kanai, Takanori Fukunaga, Koichi Clinical clustering with prognostic implications in Japanese COVID-19 patients: report from Japan COVID-19 Task Force, a nation-wide consortium to investigate COVID-19 host genetics |
title | Clinical clustering with prognostic implications in Japanese COVID-19 patients: report from Japan COVID-19 Task Force, a nation-wide consortium to investigate COVID-19 host genetics |
title_full | Clinical clustering with prognostic implications in Japanese COVID-19 patients: report from Japan COVID-19 Task Force, a nation-wide consortium to investigate COVID-19 host genetics |
title_fullStr | Clinical clustering with prognostic implications in Japanese COVID-19 patients: report from Japan COVID-19 Task Force, a nation-wide consortium to investigate COVID-19 host genetics |
title_full_unstemmed | Clinical clustering with prognostic implications in Japanese COVID-19 patients: report from Japan COVID-19 Task Force, a nation-wide consortium to investigate COVID-19 host genetics |
title_short | Clinical clustering with prognostic implications in Japanese COVID-19 patients: report from Japan COVID-19 Task Force, a nation-wide consortium to investigate COVID-19 host genetics |
title_sort | clinical clustering with prognostic implications in japanese covid-19 patients: report from japan covid-19 task force, a nation-wide consortium to investigate covid-19 host genetics |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9472186/ https://www.ncbi.nlm.nih.gov/pubmed/36104674 http://dx.doi.org/10.1186/s12879-022-07701-y |
work_keys_str_mv | AT otakeshiro clinicalclusteringwithprognosticimplicationsinjapanesecovid19patientsreportfromjapancovid19taskforceanationwideconsortiumtoinvestigatecovid19hostgenetics AT chubachishotaro clinicalclusteringwithprognosticimplicationsinjapanesecovid19patientsreportfromjapancovid19taskforceanationwideconsortiumtoinvestigatecovid19hostgenetics AT namkoongho clinicalclusteringwithprognosticimplicationsinjapanesecovid19patientsreportfromjapancovid19taskforceanationwideconsortiumtoinvestigatecovid19hostgenetics AT nakagawarakensuke clinicalclusteringwithprognosticimplicationsinjapanesecovid19patientsreportfromjapancovid19taskforceanationwideconsortiumtoinvestigatecovid19hostgenetics AT tanakahiromu clinicalclusteringwithprognosticimplicationsinjapanesecovid19patientsreportfromjapancovid19taskforceanationwideconsortiumtoinvestigatecovid19hostgenetics AT leeho clinicalclusteringwithprognosticimplicationsinjapanesecovid19patientsreportfromjapancovid19taskforceanationwideconsortiumtoinvestigatecovid19hostgenetics AT moritaatsuho clinicalclusteringwithprognosticimplicationsinjapanesecovid19patientsreportfromjapancovid19taskforceanationwideconsortiumtoinvestigatecovid19hostgenetics AT fukushimatakahiro clinicalclusteringwithprognosticimplicationsinjapanesecovid19patientsreportfromjapancovid19taskforceanationwideconsortiumtoinvestigatecovid19hostgenetics AT watasemayuko clinicalclusteringwithprognosticimplicationsinjapanesecovid19patientsreportfromjapancovid19taskforceanationwideconsortiumtoinvestigatecovid19hostgenetics AT kusumototatsuya clinicalclusteringwithprognosticimplicationsinjapanesecovid19patientsreportfromjapancovid19taskforceanationwideconsortiumtoinvestigatecovid19hostgenetics AT masakikatsunori clinicalclusteringwithprognosticimplicationsinjapanesecovid19patientsreportfromjapancovid19taskforceanationwideconsortiumtoinvestigatecovid19hostgenetics AT kamatahirofumi clinicalclusteringwithprognosticimplicationsinjapanesecovid19patientsreportfromjapancovid19taskforceanationwideconsortiumtoinvestigatecovid19hostgenetics AT ishiimakoto clinicalclusteringwithprognosticimplicationsinjapanesecovid19patientsreportfromjapancovid19taskforceanationwideconsortiumtoinvestigatecovid19hostgenetics AT hasegawanaoki clinicalclusteringwithprognosticimplicationsinjapanesecovid19patientsreportfromjapancovid19taskforceanationwideconsortiumtoinvestigatecovid19hostgenetics AT haradanorihiro clinicalclusteringwithprognosticimplicationsinjapanesecovid19patientsreportfromjapancovid19taskforceanationwideconsortiumtoinvestigatecovid19hostgenetics AT uedatetsuya clinicalclusteringwithprognosticimplicationsinjapanesecovid19patientsreportfromjapancovid19taskforceanationwideconsortiumtoinvestigatecovid19hostgenetics AT uedasoichiro clinicalclusteringwithprognosticimplicationsinjapanesecovid19patientsreportfromjapancovid19taskforceanationwideconsortiumtoinvestigatecovid19hostgenetics AT ishigurotakashi clinicalclusteringwithprognosticimplicationsinjapanesecovid19patientsreportfromjapancovid19taskforceanationwideconsortiumtoinvestigatecovid19hostgenetics AT arimuraken clinicalclusteringwithprognosticimplicationsinjapanesecovid19patientsreportfromjapancovid19taskforceanationwideconsortiumtoinvestigatecovid19hostgenetics AT saitofukuki clinicalclusteringwithprognosticimplicationsinjapanesecovid19patientsreportfromjapancovid19taskforceanationwideconsortiumtoinvestigatecovid19hostgenetics AT yoshiyamatakashi clinicalclusteringwithprognosticimplicationsinjapanesecovid19patientsreportfromjapancovid19taskforceanationwideconsortiumtoinvestigatecovid19hostgenetics AT nakanoyasushi clinicalclusteringwithprognosticimplicationsinjapanesecovid19patientsreportfromjapancovid19taskforceanationwideconsortiumtoinvestigatecovid19hostgenetics AT mutohyoshikazu clinicalclusteringwithprognosticimplicationsinjapanesecovid19patientsreportfromjapancovid19taskforceanationwideconsortiumtoinvestigatecovid19hostgenetics AT suzukiyusuke clinicalclusteringwithprognosticimplicationsinjapanesecovid19patientsreportfromjapancovid19taskforceanationwideconsortiumtoinvestigatecovid19hostgenetics AT murakamikoji clinicalclusteringwithprognosticimplicationsinjapanesecovid19patientsreportfromjapancovid19taskforceanationwideconsortiumtoinvestigatecovid19hostgenetics AT okadayukinori clinicalclusteringwithprognosticimplicationsinjapanesecovid19patientsreportfromjapancovid19taskforceanationwideconsortiumtoinvestigatecovid19hostgenetics AT koikeryuji clinicalclusteringwithprognosticimplicationsinjapanesecovid19patientsreportfromjapancovid19taskforceanationwideconsortiumtoinvestigatecovid19hostgenetics AT kitagawayuko clinicalclusteringwithprognosticimplicationsinjapanesecovid19patientsreportfromjapancovid19taskforceanationwideconsortiumtoinvestigatecovid19hostgenetics AT kimuraakinori clinicalclusteringwithprognosticimplicationsinjapanesecovid19patientsreportfromjapancovid19taskforceanationwideconsortiumtoinvestigatecovid19hostgenetics AT imotoseiya clinicalclusteringwithprognosticimplicationsinjapanesecovid19patientsreportfromjapancovid19taskforceanationwideconsortiumtoinvestigatecovid19hostgenetics AT miyanosatoru clinicalclusteringwithprognosticimplicationsinjapanesecovid19patientsreportfromjapancovid19taskforceanationwideconsortiumtoinvestigatecovid19hostgenetics AT ogawaseishi clinicalclusteringwithprognosticimplicationsinjapanesecovid19patientsreportfromjapancovid19taskforceanationwideconsortiumtoinvestigatecovid19hostgenetics AT kanaitakanori clinicalclusteringwithprognosticimplicationsinjapanesecovid19patientsreportfromjapancovid19taskforceanationwideconsortiumtoinvestigatecovid19hostgenetics AT fukunagakoichi clinicalclusteringwithprognosticimplicationsinjapanesecovid19patientsreportfromjapancovid19taskforceanationwideconsortiumtoinvestigatecovid19hostgenetics AT clinicalclusteringwithprognosticimplicationsinjapanesecovid19patientsreportfromjapancovid19taskforceanationwideconsortiumtoinvestigatecovid19hostgenetics |